Clinical Trial Update: Dopaminergic Therapy for Frontotemporal Dementia Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a dopaminergic therapy for frontotemporal dementia has completed; outcomes are not detailed in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Frontotemporal Dementia
• Frontotemporal Lobar Degeneration
• Progressive Aphasia

Drugs mentioned

• Dopaminergic therapy

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Frontotemporal Dementia, Dementia | Phase 2 | Status: COMPLETED